The increasing demand for biotherapeutics to open up the new avenue for Transfection Reagents And Equipment Market
 |
| Transfection Reagents And Equipment Market |
Market Overview:
Transfection is a process of deliberately introducing nucleic acids into
eukaryotic cells. Transfection reagents and equipment are used to deliver
genetic materials such as DNA, RNA and proteins into cells. Polyethyleneimine,
liposomes and dendrimers are commonly used as transfection reagents.
Lentiviruses and adeno-associated viruses are popular transfection equipment
used for stable gene expression in dividing and non-dividing cells.
Transfection finds wide application in biomedical research, production of
biologics and cell-based assays.
Market Dynamics:
The growing research and development activities for gene and cell therapy is a
major driver fueling the transfection reagents and equipment market growth.
Gene therapy holds potential to cure genetic disorders and cell therapy shows
promise in regenerative medicine. Further, the increasing adoption of
CRISPR/Cas9 genome editing technique for therapeutics development and better
understanding of gene function is another factor bolstering the market
expansion. However, low transfection efficiency associated with primary cells
and complexity of transfection process may hinder the market growth.
Segment Analysis
The global transfection reagents and equipment market can be segmented into
reagents and equipment. The reagents segment currently dominates the market,
with plasmid DNA sub-segment being the major revenue generator. This is because
plasmid DNA is the most commonly used type of DNA for transfections and is
relatively inexpensive.
PEST Analysis
Political: The market is positively impacted by initiatives taken by
governments across the globe to promote cell-based research. For instance,
heavy funding by governments in emerging economies to establish research hubs.
Economic: Growth in the economy increases healthcare expenditure which boosts
life science research including cell-based research driving demand.
Social: Rising incidence of infectious and chronic diseases increases R&D
for developing effective cell and gene-based therapies augmenting market
growth.
Technological: Advances in transfection technologies such as CRISPR are
simplifying procedures which is increasing adoption of transfection reagents and
equipment.
Key Takeaways
The global Transfection
Reagents And Equipment Market Demand is expected to witness high
growth, exhibiting CAGR of 9.3% over the forecast period, due to increasing
R&D investments in cell-based research. The market size for 2023 is
estimated to be US$ 1,165.6 Mn.
Regional analysis
Asia Pacific is poised to be the fastest growing region in the transfection reagents
and equipment market owing to increasing government funding in countries such
as China and India to promote life science research. North America currently
dominates led by United States due to presence of leading transfection reagent
manufacturers and major research institutions.
Key players
Key players operating in the transfection reagents and equipment market are
Qiagen NV, Promega Corporation, Polyplus-transfection SA, Mirus Bio LLC, Merck
KgaA, MaxCyte Inc., Lonza Group, Bio-Rad Laboratories Inc., and Thermo Fisher
Scientific Inc., among others.
Comments
Post a Comment